John Abramson, MD

After completing a residency in Family Medicine and a 2 year Robert Wood Johnson fellowship, Dr. John Abramson worked as a family physician for 20 years. He has been on the faculty at Harvard Medical School for 17 years, where he has taught primary care and is currently teaching health care policy. He served 7 years as chairperson of the department of family practice at Lahey Clinic.

He was twice voted “best doctor” in his area by readers of the local newspapers and three times selected by his peers as one of a handful of best family practitioners in Massachusetts. He has served as an expert in litigation involving Vioxx, Nexium, Yasmin and Yaz, Avandia, Neurontin and other drugs. And has also served as an unpaid consultant to the FBI and U. S. Department of Justice.

Dr. Abramson is the author of Overdosed America: the Broken Promise of American Medicine, published by HarperCollins in September 2004, third edition 2008. The book explains how the commercial influence on American medicine directs healthcare toward the latest pills, tests, and procedures, when the real science shows that about two thirds of our health is determined by our lifestyle habits and environment.

He has published articles in medical journals critiquing the quality of scientific evidence available to practicing physicians including:

“Are Lipid-Lowering Guidelines Evidence Based?” published in The Lancet; “Can We Trust the Evidence in Evidence Based Medicine?” in The Journal of the American Board of Family Medicine; and “Clinical Trial Data is a Public Good” published in the Journal of the American Medical Association in September 2012.

Most recently (October 22, 2013), Dr. Abramson was the lead author of a paper titled “Should people at low risk of cardiovascular disease take a statin?” published in the BMJ (formerly The British Medical Journal) He was written op-ed pieces in the New York Times, LA Times and others. His most recent op-ed in The New York Times (November 13, 2013) titled “Don’t Give More Patients Statins.

Dr. Abramson has appeared on more than 65 national television shows, including two appearances on the Today Show, and more recently on the Dr. Oz Show.

Dr. John Abramson, MD, MS: Author of Overdo$ed America

A Conversation with John Abramson, MD: Is It Time To Create a ‘Fed Board’ To Oversee Clinical Research?

Recent publications include:

Abramson JD, Rosenberg HG, Jewell N, Wright JM. Authors’ reply to Huffman and colleagues. BMJ. 2014; 348:g1523.
Abramson JD, Rosenberg HG, Jewell N, Wright JM. Authors’ reply to Huffman and colleagues. BMJ. 2014; 348:g1523.
Abramson JD, Rosenberg HG, Jewell N, Wright JM. Authors’ reply to Davis and Dietrich. BMJ. 2014; 348:g1792.
Abramson JD, Rosenberg HG, Jewell N, Wright JM. Should people at low risk of cardiovascular disease take a statin? BMJ. 2013; 347:f6123.
Rodwin MA, Abramson JD. Clinical trial data as a public good. JAMA. 2012 Sep 5; 308(9):871–2.
Abramson J, Wright JM. Are lipid-lowering guidelines evidence-based? Lancet. 2007 Jan 20; 369(9557):168–9.
Abramson J, Starfield B. The effect of conflict of interest on biomedical research and clinical practice guidelines: can we trust the evidence in evidence-based medicine? J Am Board Fam Pract. 2005 Sep–Oct; 18(5):414–8.
Spitz B, Abramson J. When health policy is the problem: a report from the field. J Health Polit Policy Law. 2005 Jun; 30(3):327–65; discussion 367–73.
Abramson JD, Rosenberg HG, Jewell N, Wright JM. Authors’ reply to Davis and Dietrich. BMJ. 2014; 348:g1792.
Abramson JD, Rosenberg HG, Jewell N, Wright JM. Should people at low risk of cardiovascular disease take a statin? BMJ. 2013; 347:f6123.
Rodwin MA, Abramson JD. Clinical trial data as a public good. JAMA. 2012 Sep 5; 308(9):871–2.
Abramson J, Wright JM. Are lipid-lowering guidelines evidence-based? Lancet. 2007 Jan 20; 369(9557):168–9.
Abramson J, Starfield B. The effect of conflict of interest on biomedical research and clinical practice guidelines: can we trust the evidence in evidence-based medicine? J Am Board Fam Pract. 2005 Sep–Oct; 18(5):414–8.
Spitz B, Abramson J. When health policy is the problem: a report from the field. J Health Polit Policy Law. 2005 Jun; 30(3):327–65; discussion 367–73.